Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Reichelderfer

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Annals of Internal Medicine|March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working GroupR T D'Aquila, V A Johnson, S L Welles, et al.
Journal of Clinical Microbiology|February 12, 1998
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisonsD Brambilla, S Leung, J Lew, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
AIDS (London, England)|November 4, 2000
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study TeamP S Reichelderfer, R W Coombs, D J Wright, et al.
Journal of Clinical Microbiology|July 1, 1996
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working GroupR W Shafer, M A Winters, D L Mayers, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Annals of Internal Medicine|March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working GroupR T D'Aquila, V A Johnson, S L Welles, et al.
Journal of Clinical Microbiology|February 12, 1998
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisonsD Brambilla, S Leung, J Lew, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
AIDS (London, England)|November 4, 2000
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study TeamP S Reichelderfer, R W Coombs, D J Wright, et al.
Journal of Clinical Microbiology|July 1, 1996
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working GroupR W Shafer, M A Winters, D L Mayers, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
Pageof 3